$Rocket Lab USA, Inc.(RKLB)$ I didn't buy based on the charts. Short term, there's a head and shoulders pattern and this looks like it's going down to test $58–59 again. It'll probably tap that area and bounce from there.
$Rocket Lab USA, Inc.(RKLB)$ A bullish doji star pattern is in play, with upside potential of around 6.0% from the last closing price. The signal got confirmation once price crossed above the 64.16 level, and the valid average buying price now stands at 65.87. The falling wedge oversold run appears to be over.
Rocket Lab builds their own rockets, their own satellites, their own spacecraft. $Rocket Lab USA, Inc.(RKLB)$ is a self-producer of just about everything space-related.
Comparing $Rocket Lab USA, Inc.(RKLB)$ to $AST SpaceMobile, Inc.(ASTS)$ isn't really close. End-to-end companies have an easier path to growth. It's common sense that a more versatile company has more opportunities. Both are important for space, but one has nearly double the market cap at the same price per share. Rocket Lab.
$Rocket Lab USA, Inc.(RKLB)$ Not many people are in the camp that thinks September will actually be a strong month. That's part of why stocks look like a buy to me.
$AST SpaceMobile, Inc.(ASTS)$ I'm not sure why there's so much tension around RKLB. Different market, different product. Both are leading in their own space and both look extremely bullish right now. Just own both and be happy.
Rocket Lab's next launch from LC-1 will be in a launch window from August 15th to September 4th. This is likely for the next iQPS mission "The Lightning God Defends". It also leaves plenty of room for more launches this month. $Rocket Lab USA, Inc.(RKLB)$
$Rocket Lab USA, Inc.(RKLB)$ This thing is looking promising and primed for a rip. Bears are out in full force, but there's just no traction either way right now.
Two space names reporting tonight: $AST SpaceMobile, Inc.(ASTS)$ and RKLB. $AST SpaceMobile, Inc.(ASTS)$ — Revenue seen around $35M, which is huge percentage growth off a small base, with adjusted loss around $0.32 per share. The real focus is whether the launch bottleneck since the Bluebird 7 failure in May has been resolved. Losses and opex have been climbing fast. The Street's split on this one, with an average target implying roughly 24% upside. $Rocket Lab USA, Inc.(RKLB)$ — Revenue seen around $232M, roughly 60% year-over-year, with a loss of about $0.06 per share, right at the guidance midpoint. Watching for Space Systems profitability, w
$Rocket Lab USA, Inc.(RKLB)$ ASTS just had one of its worst months ever. But the business itself kept stacking wins. Contracts, missions, new launch capacity, and the $Iridium(IRDM)$ deal all moved forward. The stock got crushed. The execution didn't. That's exactly why I started building a position.
$Rocket Lab USA, Inc.(RKLB)$ The market seems to have priced in a higher chance of a rate hike now. A lot of money has been rotating out of speculative names. If a hike doesn't actually happen, these high-beta stocks could fly right back up.
$Rocket Lab USA, Inc.(RKLB)$ This has played out before. Back in April 2025, the stock dropped to around $16. People were saying Neutron would never fly and the company would never make money. Some sold, others doubled down. Months later, RKLB rerated to $150, and those who kept their focus on the long-term thesis were rewarded. Now it is around $60, but the company is arguably in a stronger position than it was at those highs — with the Iridium acquisition and a $266M Space Force contract now in the picture. Short-term price action can swing sentiment around, but the fundamentals are what drive the next chapter. I am still bullish.
$Rocket Lab USA, Inc.(RKLB)$ is down 60% from its all-time high. Shares have been coiling heavily intraday through the $60.05 to $64.95 demand range. Shorts are still leaning hard into macro volatility, but it looks like smart money is quietly absorbing liquidity off key support. High short interest combined with solid demand suggests there's a massive short squeeze risk building up here. Sharing some charts and notes I've been tracking.